1. Cush JJ, Medsger TA Jr, Christy WC, Herbert DC, Cooperstein LA. Adult-onset Stills disease. Clinical course and outcome. Arthritis Rheum. 1987. 30:186–194.
2. Babu KS, Belgi G. Management of cutaneous drug reactions. Curr Allergy Asthma Rep. 2002. 2:26–33.
Article
3. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol. 2003. 4:561–572.
Article
4. Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India. J Postgrad Med. 2001. 47:95–99.
5. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med. 2001. 345:804–809.
Article
6. Lucchina LC, Wilson ME, Drake LA. Dermatology and the recently returned traveler: infectious diseases with dermatologic manifestations. Int J Dermatol. 1997. 36:167–181.
Article
7. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978. 2:1116–1118.
Article
8. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA. 1993. 269:390–391.